Immunology (Liz - Transplantation) Flashcards

1
Q

How many different MHC class I and II haplotypes are there?

A

6 Class I molecules

12 Class II molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the advantage and disadvantage of having different MHC haplotypes?

A

Advantage: Good diversity for surviving plagues etc

Disadvantage: Matching a donor with a recipient in transplant surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most people are heterozygous for MHC at each locus, true or false?

A

True

- 2 MHC haplotypes on each cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do people express 2 different MHC haplotypes?

A

Alleles from mother and father are coexpressed

- Co-dominant relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Due to MHC coexpression, how many possible haplotype combinations are there in mating?

A

4

e.g
Mum: Red and blue
Dad: Yellow and green

Offspring can be:
Blue and green
Blue and yellow
Red and green
Red and yellow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 types of graft?

A

Autograft: skin from one place moved to another

Isograft: graft between genetically identical individuals

Allograft: between 2 individuals of the same species

Xenograft: between different species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which grafts are usually accepted and not accepted?

A

Auto and isografts usually excepted

Allo and xenografts usually not accepted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 4 laws of transplantation?

A

1) A to A = accepted
2) B to A = rejected
3) B to AB = accepted
4) AB to B = rejected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 2 types of allogeneic rejection?

A

1) First set (new response)
2) Second set (due to memory T cells)

As a result of a T cell mediated anti-graft response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the process of graft acceptance, first set rejection and second set rejection

A

Acceptance:

1) Grafted epidermis
2) Day 3-7 - revascularisation
3) Day 7-10 - Healing
4) Day 12-14 - Resolution

First set rejection:

1) Grafted epidermis
2) Day 3-7 - revascularisation
3) Day 7-10 - cellular infiltration
4) Day 10-14 - thrombosis and necrosis

Second set rejection:

1) Grafted epidermis
2) Day 3-4 - cellular infiltration
3) Day 5-6 - thrombosis and necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the direct and indirect recognition of alloantigens in grafted organs

A

Direct:

  • Recognition (by recipient helper and cutotoxic T cells) of donor graft antigens (peptide and foreign MHC) directly on the surface of the donor APCs that migrate from graft to local lymph nodes
  • Activated T cell migrate and destroy the graft via cell mediated cytotoxicity

Indirect:
- Recognition of processed and presented donor antigenic peptides on the recipients own APCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does a T cell response to a foreign antigen on a FOREIGN MHC?

A
  • Known as allorecognition

- Non-self MHC similar enough to self MHC leading to a cross reaction giving a T cell response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What innate and adaptive immune cells are involved in acute graft rejection?

A

Innate:
NK cells and polymorph leucocytes

Adaptive:
B cells and CD8+ cytotoxic T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the roles of NK cells in graft rejection?

A
  • Produces IFN-gamma that upregulates MHC class I and II expression on endothelial cells, so alloreactive T cell recognition is easier
  • NK cells infiltrating transplant tissue produce cytokines that attract inflammatory leukocytes to transplant site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which 3 graft types show the best survivial?

A

Kidney, heart and cornea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of therapy needs to be administered along side any allograft other than cornea transplants?

A

Immunosuppressive therapy

17
Q

How is HLA tissue typing performed?

A
  • White blood cells from donor and recipient added to seperate wells of microtitre plate
  • If HLA-A allele 2 is present, antibodiy will bind to cell
  • Addition of complement that binds to antibody will make pores in the cell
  • Addition of dye - will be taken up by cells with pores - evaluation by microscopy
18
Q

Why do the results of HLA tissue typing have multiple different wells for each donor?

A

Because lymphocytes express numerous HLA antigens - therefore testing is done with numerous antibodies specific for each antigen

19
Q

Describe the effect of MHC class I and II matching on graft survival

A
  • Mismatching of MHC class II is more severe than mismatching of MHC class I (HLA-A or B)
  • Mismatching of both greatly accelerates rejection
20
Q

How does the Luminex cross-matching assay work?

A

1) Microbeads with impregnated flurochromes of different intensites used
2) Each bead carries a different HLA allele
3) Beads with allele mixed with patients serum to see if they have pre-existing antibodies to the allele
4) Anti-HLA antibodies will bind to beads
5) A second phycoerythrin (PE) anti-human IgG antibody is added which will bind to primary antibody
6) Beads passed through machine that works like a flow cytometer
7) Based through laser that excites both fluorescently labelled secondary antibody and flurochrome allowing detection and identification of antibody

21
Q

What can occur if the recipient has existing antibodies against the donor antigen?

A

Hyperacute graft rejection

  • antibodies immediately bind to vascular endothelium of graft, causing complement and clotting factors to activate
  • Complement split products attract neutrophils that release lytic enzymes
  • platelets form and cause vascular blockage
  • Thrombosis and necrosis of graft
22
Q

Describe how chronic rejection of an organ can occur

A

1) Binding of anti-HLA antibodies to blood vessels of transplanted organs
2) This recruits monocytes and neutrophils bearing Fc receptors which leads to ADCC (antibody dependant cytotoxicity)
3) Accumulating damage leads to chronic inflammation and vasoconstriction
4) Over time vessels become obstructed, ischemic and fibrotic

23
Q

What are privileged sites? Give some examples

A

Areas that a graft can be accepted without rejection because they do not have lymphatic vessels and sometimes no blood vessels
- Therefore no immune cells can reach to attack foreign antigens

e.g cornea, uterus, testes, brain

24
Q

Give a very common example of an allograft that is not rejected

A

The foetus!!!
Carries MHC from mum and dad

An example of AB to A but is accepted not rejected!

25
Q

Describe the stages and components of the immune system that lead to damage of a foreign transplanted organ

A
  • APCs activate T helper cells
  • T helper cells release cytokines:

> IL-2 and IFN-gamma required for cytotoxic T cell activation

> IL-2,4 and 5 involved in B cell activation which secrete antibodies

> Lymphotoxin and IFN-gamma together activate macrophages

  • Complement activated via classical pathway after binding to antibody/antigen complexes within grafted organ

(See diagram, slide 35 of transplant lectures)

26
Q

Name some current and potential future immunotherapies for reducing rejection

A

Current: Drug triple therapy

  • Azothioprine (mitotic inhibitor, inhibits lymphocyte proliferation)
  • Prednisolone (anti-imflammatory)
  • Cyclosporin ( Inhibits IL-2 and IL-2 gene transcription)

Potential future:

  • Antibodies to CD3, 40 and 25
  • Soluble IL-1 receptors
  • IL-2 analogs
  • Antibodies to IL-2R
27
Q

What is ICOS?

A

Inducible T cell stimulator (CD28 superfamily)

28
Q

How is ICOS targeted in a new potential therapy to prolong grafts?

A

Anti-ICOS antibodies

  • suppress T cell activation within a graft
  • When combined with cyclosporin A, graft remained permanently unaffected in an animal model
  • suggests that is prevents both acute and chronic rejection
29
Q

How do anti-IL-2R antibodies work to increase graft survival?

A

Monoclonal antibody binds to IL-2R and prevents IL-2 binding

  • Binding on T helper cells suppresses their proliferation
  • Binding on CD8 T cells prevents their activation
30
Q

How do IL-2 analogues work to increase graft survival?

A

Bind in place of IL-2 to IL-2R

  • Less IL-2 binds
  • Works the same as anti-IL-2R antibodies
31
Q

How can IL-2 analogues be altered to kill T helper cells?

A

Conjugated with a toxin

32
Q

Graft rejection can be suppressed by blocking co-stimulation of T cells by binding what soluble ligand with B7?

A

CTLA-4lg

33
Q

After kidney, what is the most common transplant?

A

Bone marrow transplant

34
Q

What is a bone marrow transplant often used to treat?

A

Leukaemia and severe combined immunodeficiency disease

35
Q

What is graft versus host disease (GvHD)?

A

A complication after recieving a graft in which immune cells in the transplanted tissue recognise the components of the host as foreign

36
Q

Why does GvHD occur in bone marrow transplants?

A
  • Mature donor T cells contaminate the preparation of the stem cells
  • These recognise alloantigens present on host cells
37
Q

What % of bone marrow transplant patients get GvHD?

A

50-70%

38
Q

What is the result of GvHD?

A

Inflammatory disease, leading to cytokine production that affects the skin, GI tract and liver
- In severe cases, there is GI haemorrhage and liver failure

39
Q

What can be done as an alternative to a bone marrow transplant?

A

Purging of tumour cells in the bone marrow by:
- monoclonal antibodies and complement
- antibody-toxin conjugates
or
- antibodies coupled with magnetic beads (interfere with mitosis)